Pharmaceutical imports

Search documents
美国_更新关税假设-US_ Updating tariff assumptions
2025-07-28 01:42
Summary of Key Points from the Conference Call Industry Overview - The conference call primarily discusses the **tariff policies** and their implications on the **US economy** and **global trade** dynamics, particularly focusing on the **steel, aluminum, copper, pharmaceuticals, semiconductors**, and **drones** industries. Core Insights and Arguments - The **average effective tariff rate** is revised up to **19.5%** from **15.2%**, marking a **4.3 percentage points (pp)** increase due to escalated trade tensions under the Trump administration [4][7][28]. - New assumptions regarding **Section 232 tariffs** have been introduced, with **steel and aluminum tariffs** raised to **50%** and potential **50% tariffs on copper** products being considered [5][8]. - The **Department of Commerce** has initiated new investigations under **Section 232** for products including **polysilicon** and **drones**, indicating a broader scope for future tariffs [5][8]. - Despite aggressive tariff actions, factors such as favorable treatment of non-USMCA compliant imports from **Mexico** and **Canada**, and a significant decline in imports from **China**, have limited the rise in the average effective tariff rate [7][10][22]. Additional Important Points - The **realized tariff rate** was reported to be slightly below **10%** as of May, which is significantly lower than the announced tariff rates [7][14]. - The **share of imports from China** has sharply declined from **13.4%** in 2024 to **7.2%** in May 2025, with the effective tariff rate against China reaching **47.8%**, the highest among major US trading partners [22][24]. - The **reciprocal tariffs** against targeted countries are expected to average **20%**, up from the current **10%**, influenced by recent agreements with countries like **Indonesia** and **the Philippines** [8][9]. - Risks to the tariff expectations are two-sided; adjustments to exemptions for **Mexico** and **Canada** could lead to further increases, while potential postponements of tariff increases could pose downside risks [26][27]. Implications for Monetary Policy - The revised tariff assumptions pose **upside risks** to inflation and **downside risks** to economic growth forecasts, which could complicate the Federal Reserve's objectives regarding price stability and employment [28]. This summary encapsulates the critical insights from the conference call, highlighting the evolving landscape of US tariff policies and their broader economic implications.